Latest Conference Articles

mRNA: Unparalleled Potential as a Drug

November 7th 2023

Chris Spivey, editorial director for Pharmaceutical Technology®, discusses mRNA advances and the background for the leading scientific conference for the field, with host and co-organizer CureVac CEO Dr. Alexander Zehnder.

Discussing Oligonucleotide Challenges in Analytics and Purification (AAPS PharmSci 360)

November 7th 2023

Matthew Lauber, senior director—Cell and Gene Therapy, Consumables & Lab Automation, at Waters Corporation discusses the analytical and downstream purification challenges of oligonucleotides.

Alliance for mRNA Medicines Officially Launched in Germany

November 6th 2023

The Alliance for mRNA Medicines (AMM) was officially launched at the 11th International mRNA Health Conference in Berlin, Germany.

Distinguishing E&L Testing for Combination Products (AAPS PharmSci 360)

November 6th 2023

Dujuan Lu, PhD, global leader—E&L, SGS Health Sciences, talks about the differences in designing E&L testing for combination products vs. conventional pharmaceuticals.

Increasing Solubility with Zerion Pharma at CPHI Barcelona

November 6th 2023

Pharmaceutical Technology Europe® spoke with Ole Wiborg from Zerion Pharma, a Danish pharmaceutical development company, at the inaugural Start-Up Market on the show floor at CPHI Barcelona 2023.

Discussing E&L Study Design Between ISO and USP (AAPS PharmSci 360)

November 6th 2023

Dujuan Lu, PhD, global leader—E&L, SGS Health Sciences, discusses the differences in how E&L study design should be approached based on whether the study is following ISO or USP standards.

Key E&L Issues to Consider During Formulation (AAPS PharmSci 360)

November 3rd 2023

Dujuan Lu, PhD, global leader—E&L, SGS Health Sciences, recommends some key issues that pharma manufacturers should consider when formulating products that require a medical device.

Improving Intranasal Treatments with Dr. Ferrer BioPharma at CPHI Barcelona

November 3rd 2023

Pharmaceutical Technology Europe® spoke with Gustavo Ferrer from Dr. Ferrer BioPharma, a US company focused on innovative intranasal medications, at the inaugural Start-Up Market on the show floor at CPHI Barcelona 2023.

Converting to Continuous Manufacturing with CONTINUUS Pharmaceuticals at CPHI Barcelona

November 3rd 2023

Pharmaceutical Technology Europe® spoke with Leonardo Vincenzi from CONTINUUS Pharmaceuticals, a US company that specializes in process development, at the inaugural Start-Up Market on the show floor at CPHI Barcelona 2023.

Ensuring the Next Generation of Analytical Experts (AAPS PharmSci 360)

November 3rd 2023

Hollie Barton, senior director, Chromatographic Services, for the PPD clinical research business of Thermo Fisher Scientific, highlights one approach to ensuring the continuation of analytical expertise.